147 Results

People

  1. Motzer
    Motzer
  2. Russo
    Russo
  3. Mazumdar
    Mazumdar
  4. Schwartz
    Schwartz
  5. Bacik
    Bacik
  6. Feldman
    Feldman
  7. Ginsberg
    Ginsberg
  8. Molina
    Molina
  9. Reuter
    Reuter
  10. Patil
    Patil

Groups

  1. Department of Medicine (147)
  2. Genitourinary Oncology Service (147)
  3. Solid Tumor Oncology Division (147)
  4. Radiology, Department of (37)
  5. Body Imaging Service (34)
  6. Surgery (33)
  7. Urology (33)
  8. Epidemiology and Biostatistics (16)
  9. Biostatistics Service (15)
  10. Division of Subspecialty Medicine (10)
  1. "kidney carcinoma"
  2. "Robert Motzer"
Formats
  1. Journal Article (147)
Groups
  1. Department of Medicine (147)
  2. Genitourinary Oncology Service (147)
  3. Solid Tumor Oncology Division (147)
  4. Radiology, Department of (37)
  5. Body Imaging Service (34)
  6. Surgery (33)

More Groups

People
  1. Robert Motzer (147)
  2. Paul Russo (27)
  3. Madhu Mazumdar (19)
  4. Lawrence Schwartz (17)
  5. Victor Reuter (16)
  6. Darren Feldman (15)

More People

Years
  1. 2019 (1)
  2. 2017 (1)
  3. 2016 (2)
  4. 2015 (8)
  5. 2014 (5)
  6. 2013 (5)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. Investigational New Drugs (10)
  3. Cancer (9)
  4. Clinical Cancer Research (7)
  5. Clinical Genitourinary Cancer (7)
  6. Journal of Urology (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (24)
  2. Elsevier Science, Inc. (17)
  3. Elsevier Inc. (14)
  4. Wiley Blackwell (14)
  5. Springer (13)
  6. Oxford University Press (11)

More Publishers

Results (147)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations
    Journal Article

    Manley, B. J.; Reznik, E.; Ghanaat, M.; Kashan, M.; Becerra, M. F.; Casuscelli, J.; Tennenbaum, D.; Redzematovic, A.; Carlo, M. I.; Sato, Y.; more...
    Urologic Oncology: Seminars and Original Investigations (2019)

    Fulltext@MSK | Save
  • Genomic characterization of renal medullary carcinoma and treatment outcomes
    Journal Article

    Carlo, M. I.; Chaim, J.; Patil, S.; Kemel, Y.; Schram, A. M.; Woo, K.; Coskey, D.; Nanjangud, G. J.; Voss, M. H.; Feldman, D. R.; more...
    Clinical Genitourinary Cancer (2017)

    Fulltext@MSK | Save
  • Prognostic biomarkers for response to vascular endothelial growth factor-targeted therapy for renal cell carcinoma
    Journal Article

    Winer, A. G.; Motzer, R. J.; Hakimi, A. A.
    Urologic Clinics of North America (2016)

    Fulltext@MSK | Save
  • Bevacizumab monotherapy as salvage therapy for advanced clear cell renal cell carcinoma pretreated with targeted drugs
    Journal Article

    Lee, C. H.; Hötker, A. M.; Voss, M. H.; Feldman, D. R.; Woo, K. M.; Patil, S.; Coskey, D. T.; Akin, O.; Hsieh, J. J.; Motzer, R. J.
    Clinical Genitourinary Cancer (2016)

    Fulltext@MSK | Save
  • Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients
    Journal Article

    Donskov, F.; Michaelson, M. D.; Puzanov, I.; Davis, M. P.; Bjarnason, G. A.; Motzer, R. J.; Goldstein, D.; Lin, X.; Cohen, D. P.; Wiltshire, R.; more...
    British Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Cabozantinib versus everolimus in advanced renal-cell carcinoma
    Journal Article

    Choueiri, T. K.; Escudier, B.; Powles, T.; Mainwaring, P. N.; Rini, B. I.; Donskov, F.; Hammers, H.; Hutson, T. E.; Lee, J. L.; Peltola, K.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Nivolumab versus everolimus in advanced renal-cell carcinoma
    Journal Article

    Motzer, R. J.; Escudier, B.; McDermott, D. F.; George, S.; Hammers, H. J.; Srinivas, S.; Tykodi, S. S.; Sosman, J. A.; Procopio, G.; Plimack, E. R.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Development and validation of a prognostic nomogram for progression-free survival in patients with advanced renal cell carcinoma treated with pazopanib
    Journal Article

    Kattan, M. W.; Sternberg, C. N.; Mehmud, F.; Bhatt, K.; McCann, L.; Motzer, R. J.
    Oncology (2015)

    Fulltext@MSK | Save
  • IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma
    Journal Article

    Xu, C. F.; Johnson, T.; Garcia-Donas, J.; Choueiri, T. K.; Sternberg, C. N.; Davis, I. D.; Bing, N.; Deen, K. C.; Xue, Z.; McCann, L.; more...
    British Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Sunitinib as a paradigm for tyrosine kinase inhibitor development for renal cell carcinoma
    Journal Article

    Lee, C. H.; Motzer, R. J.
    Urologic Oncology: Seminars and Original Investigations (2015)

    Fulltext@MSK | Save